AGC Biologics A/S: Financial statements 2015
CVR: 25950941
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
AGC Biologics A/S (CVR 25950941) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 320,466,000 and a net result of DKK 8,373,000 compared with DKK 3,181,000 the year before. That is an increase of 3% compared with the year before. The profit margin was 2.6%. Equity in the 2015 report amounted to DKK 147,895,000. The solvency ratio was 36.6%. The company had 209 employees in the financial year.
- Revenue
- DKK 320,466,000
- Gross Profit
- DKK 62,337,000
- Profit/Loss
- DKK 8,373,000
- Equity
- DKK 147,895,000
- Total Assets
- DKK 404,229,000
- Employees
- 209
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 320.5M | 62.3M | 8.4M | 147.9M | 209 |
| 2014 | 311.1M | 45.8M | 3.2M | 139.5M | 199 |
| 2013 | - | 37.2M | -128K | 136.3M | 185 |
Official annual report
How creditworthy is AGC Biologics A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
AGC Biologics A/S has published its annual report for 2014. Revenue came to DKK 311,091,000, and the net result was DKK 3,181,000.
About AGC Biologics A/S
AGC Biologics A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2001. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named CMC BIOLOGICS A/S and CMC BIOPHARMACEUTICALS A/S. The management consists of Kasper Møller. The board consists of Tadashi Murano (chair), Alberto Santagostino, Kasper Møller and Mai Iwaya. The company is owned by Asahi Glass Co., Ltd.. The company has 1,503 employees (2026). In 2025, the company reported revenue of DKK 1,959,639,000 and a net result of DKK -328,010,000 compared with DKK -115,005,000 the year before. Equity in the 2025 report amounted to DKK 312,021,000.
